Skip to main content

Table 2 Evaluation of antimicrobial agents used, and microorganisms identified in ASB (N = 104)

From: Evaluation of asymptomatic bacteruria management before and after antimicrobial stewardship program implementation: retrospective study

Number of antimicrobial agents, n 151
Duration, mean 12 d
Route of administration, n (%)
 IVa 89 (59)
 POb 46 (30.4)
 IV to PO 16 (10.6)
Type of antimicrobial agents, n (%)
Quinolones 29 (19.2)
β-lactam 73 (48.3)
  Penicillin 11 (7.28)
  Cephalosporin  
   2nd generation 33 (21.85)
   3rd generation 29 (19.21)
Carbapenem 44 (29.14)
Vancomycin 1 (0.66)
Others 4 (2.65)
Microorganisms identified (N = 116)
Gram-positive, n (%) 11 (9.40)
  Enterococcus 7 (6.03)
  Coagulase negative staph 2 (1.72)
  Streptococcus group B 2 (1.72)
Gram-negative, n (%)c 105 (90.2)
  E. coli 54 (46.55)
  K. pneumonie 23 (19.83)
  Pseudomonas 13 (11.21)
  Citrobacter 3 (2.59)
  others 12 (10.35)
  1. aIV = intravenous; bPO = orally
  2. c Multidrug Resistance was 45 (38.7%) isolates in the urine